Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma

Ann Hematol. 2009 Mar;88(3):285-6. doi: 10.1007/s00277-008-0578-5. Epub 2008 Aug 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Combined Modality Therapy / methods
  • Drug Therapy, Combination
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy
  • Lymphoma, Mantle-Cell / surgery*
  • Male
  • Melphalan / administration & dosage*
  • Renal Dialysis*
  • Transplantation Conditioning* / methods
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*

Substances

  • Vidarabine
  • fludarabine
  • Melphalan